KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lam Research (LRCX) EBT Margin (2016 - 2025)

Historic EBT Margin for Lam Research (LRCX) over the last 17 years, with Q4 2025 value amounting to 34.36%.

  • Lam Research's EBT Margin rose 35600.0% to 34.36% in Q4 2025 from the same period last year, while for Dec 2025 it was 34.1%, marking a year-over-year increase of 39300.0%. This contributed to the annual value of 32.32% for FY2025, which is 30700.0% up from last year.
  • Per Lam Research's latest filing, its EBT Margin stood at 34.36% for Q4 2025, which was up 35600.0% from 34.92% recorded in Q3 2025.
  • Over the past 5 years, Lam Research's EBT Margin peaked at 34.92% during Q3 2025, and registered a low of 24.26% during Q1 2023.
  • Moreover, its 5-year median value for EBT Margin was 30.93% (2024), whereas its average is 30.62%.
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 50000bps in 2021, then crashed by -36800bps in 2023.
  • Quarter analysis of 5 years shows Lam Research's EBT Margin stood at 32.09% in 2021, then fell by -2bps to 31.3% in 2022, then dropped by -8bps to 28.92% in 2023, then increased by 7bps to 30.81% in 2024, then rose by 12bps to 34.36% in 2025.
  • Its EBT Margin stands at 34.36% for Q4 2025, versus 34.92% for Q3 2025 and 34.4% for Q2 2025.